GC Medical Science Corp 142280

Morningstar Rating
₩3,280.00 +30.00 (0.92%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

142280 is trading at a LOCK|?t$L? premium.
Price
₩3,250.00
Fair Value
LOCK|Fv.^C&%Dm^
Uncertainty
LOCK|$X^
1-Star Price
LOCK|?D.?@R^<
5-Star Price
LOCK|Xn.%M&>Vv
Economic Moat
LOCK|MNH
Capital Allocation
—

Trading Information

Previous Close Price
₩3,250.00
Day Range
₩3,230.00–3,350.00
52-Week Range
₩2,200.00–6,660.00
Bid/Ask
₩3,250.00 / ₩3,280.00
Shares Outstanding
23.96M
Market Cap
₩78.60B
Volume/Avg
598,774 / 3M

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
0.87
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
—

Company Profile

GC Medical Science Corp is engaged in the manufacturing of medical supplies and related other medications. The company has developed and distributed a variety of sophisticated reagents to medical institutions in Korea and international markets around the world, including the U.S., Russia, Europe, Africa, Middle East, and India. Its reagents include infectious diseases (HIV, HBV, HCV etc.) test reagents, and tumor marker and parasitological test reagents.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
134

Valuation

Metric
142280
Price/Earnings (Normalized)
—
Price/Book Value
1.46
Price/Sales
0.87
Price/Cash Flow
13.97
Price/Earnings
142280

Financial Strength

Metric
142280
Quick Ratio
0.77
Current Ratio
1.47
Interest Coverage
−0.15
Quick Ratio
142280

Profitability

Metric
142280
Return on Assets (Normalized)
−0.23%
Return on Equity (Normalized)
−0.47%
Return on Invested Capital (Normalized)
2.24%
Return on Assets
142280

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
LOCK|$jjMNC&<LOCK|F$&&X$70B
Teva Pharmaceutical Industries Ltd
TEVA
LOCK|HpmmL>WLOCK|FQ#Dl$46B
Haleon PLC ADR
HLN
LOCK|K@gN<^LOCK|m?$$45B
Zoetis Inc Class A
ZTS
LOCK|lTy>lwLLOCK|&P#$33B
Viatris Inc
VTRS
LOCK|>CQ@qVHLOCK|RD$21B
Elanco Animal Health Inc
ELAN
LOCK|x!LOCK|flt$11B
Dr Reddy's Laboratories Ltd ADR
RDY
LOCK|h><sYb>LOCK|q<$11B
Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
LOCK|Lv@f!x@LOCK|#Xt$6B
Prestige Consumer Healthcare Inc
PBH
LOCK|@?^&&^LLOCK|KL$&$$2B
Perrigo Co PLC
PRGO
LOCK|?sdsyK!LOCK|<@d$2B

Sponsor Center